Literature DB >> 2419511

Neuropsychological syndromes in presenile dementia due to cerebral atrophy.

D Neary, J S Snowden, D M Bowen, N R Sims, D M Mann, J S Benton, B Northen, P O Yates, A N Davison.   

Abstract

In a prospective study of 24 patients with presenile dementia associated with cerebral atrophy, clinical and psychological characteristics of patients' disorder were examined in relation to pathological and chemical findings obtained from tissue analysis following cerebral biopsy. The histological features of Alzheimer's disease were found in 75% of cases, but not in 25%. Distinctive patterns of neuropsychological breakdown emerged allowing clinical grouping of patients. While clinical patterns were helpful in differentiating Alzheimer's disease from non-Alzheimer's disease, there was not an absolute concordance between clinical and patho-chemical groupings. The findings, which support the notion that the "cerebral atrophies" represent a heterogeneous group of conditions, have relevance for the clinical diagnosis of presenile dementia.

Entities:  

Mesh:

Year:  1986        PMID: 2419511      PMCID: PMC1028682          DOI: 10.1136/jnnp.49.2.163

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  EEG in presenile dementia related to cerebral blood flow and autopsy findings.

Authors:  G Jóhannesson; A Brun; I Gustafson; D H Ingvar
Journal:  Acta Neurol Scand       Date:  1977-08       Impact factor: 3.209

2.  Cerebral transmitter precursors and metabolites in advanced renal disease.

Authors:  P A Sullivan; D Murnaghan; N Callaghan; B D Kantamaneni; G Curzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-07       Impact factor: 10.154

3.  Limbic lobe involvement in presenile dementia.

Authors:  A Brun; L Gustafson
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-11-14

4.  The estimation of neuronal population density by a robust distance method.

Authors:  W A Aherne; P J Diggle
Journal:  J Microsc       Date:  1978-12       Impact factor: 1.758

5.  Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study.

Authors:  A Brun; L Gustafson
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-12-31

6.  Neurofibrillary pathology and protein synthetic capability in nerve cells in Alzheimer's disease.

Authors:  D M Mann; D Neary; P O Yates; J Lincoln; J S Snowden; P Stanworth
Journal:  Neuropathol Appl Neurobiol       Date:  1981 Jan-Feb       Impact factor: 8.090

7.  A comparison of an improved o-phthalaldehyde fluorometric method and high pressure liquid chromatography in the determination of brain 5-hydroxyindoles of rats treated with L-tryptophan and p-chlorophenyl-alanine.

Authors:  G Curzon; B D Kantamaneni; M D Tricklebank
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

8.  [14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex.

Authors:  N R Sims; D M Bowen; A N Davison
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

9.  EEG and cognitive impairment in presenile dementia.

Authors:  G Johannesson; B Hagberg; L Gustafson; D H Ingvar
Journal:  Acta Neurol Scand       Date:  1979-05       Impact factor: 3.209

10.  Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.

Authors:  M Rossor; J Fahrenkrug; P Emson; C Mountjoy; L Iversen; M Roth
Journal:  Brain Res       Date:  1980-11-10       Impact factor: 3.252

View more
  33 in total

1.  Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.

Authors:  P S Mathuranath; J H Xuereb; T Bak; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

2.  Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography.

Authors:  P Goulding; A Burjan; R Smith; R Lawson; J Snowden; B Northen; D Neary; H Testa
Journal:  Eur J Nucl Med       Date:  1990

Review 3.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

Review 4.  Medicine in the elderly.

Authors:  P Diggory; A Homer; J Liddle; C F Pratt; S Samadian; R Tozer; C Weinstein
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

5.  Approach to atypical Alzheimer's disease and case studies of the major subtypes.

Authors:  Bradford C Dickerson; Scott M McGinnis; Chenjie Xia; Bruce H Price; Alireza Atri; Melissa E Murray; Mario F Mendez; David A Wolk
Journal:  CNS Spectr       Date:  2017-02-15       Impact factor: 3.790

6.  Subcortical vascular disease in elderly patients with treatment resistant depression.

Authors:  S Simpson; P R Talbot; J S Snowden; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

7.  Alzheimer's disease: a correlative study.

Authors:  D Neary; J S Snowden; D M Mann; D M Bowen; N R Sims; B Northen; P O Yates; A N Davison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

8.  Progressive aphasia with right-sided extrapyramidal signs: another manifestation of localised cerebral atrophy.

Authors:  P J Goulding; B Northen; J S Snowden; N Macdermott; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

9.  Cognitive correlates of metamemory in Alzheimer's disease.

Authors:  Danielle Shaked; Meagan Farrell; Edward Huey; Janet Metcalfe; Sarah Cines; Jason Karlawish; Elizabeth Sullo; Stephanie Cosentino
Journal:  Neuropsychology       Date:  2014-05-12       Impact factor: 3.295

10.  Clinicopathologic study of Alzheimer's disease: Alzheimer mimics.

Authors:  Yong S Shim; Catherine M Roe; Virginia D Buckles; John C Morris
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.